Literature DB >> 21410841

Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

E M Vingolo1, R Di Fabio, S Salvatore, G Grieco, E Bertini, V Leuzzi, C Nesti, A Filla, A Tessa, F Pierelli, F M Santorelli, C Casali.   

Abstract

BACKGROUND: Myelinated retinal nerve fibers are considered a hallmark of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) in French Canadian patients. The demonstration of a worldwide distribution of this disease, as well as the almost invariable presence of a normal retina on fundoscopy in cases outside Canada, suggests that more quantitative methodologies are needed to assess the retina in ARSACS.
METHODS: To characterize better the retinal features of ARSACS, we studied five Italian patients by means of optical coherence tomography (OCT), a processing method that allows the creation of three-dimensional images with micrometer resolution. We compared OCT characteristics in ARSACS with those obtained from five subjects with persistent myelination of the retina, a rare congenital non-progressive anomaly.
RESULTS: Four patients with ARSACS showed myelinated retinal nerve fibers on ophthalmoscopy, corresponding to an increased thickness of the retina on OCT, a characteristic not present in the subjects with persistent myelination of the retina.
CONCLUSIONS: Myelinated retinal fibers are not rare in Italian patients with ARSACS. This finding may be the consequence of the thickening of the retina, as detected by OCT.
© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.

Entities:  

Mesh:

Year:  2011        PMID: 21410841     DOI: 10.1111/j.1468-1331.2010.03335.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  New findings in the ataxia of Charlevoix-Saguenay.

Authors:  José Gazulla; Isabel Benavente; Ana Carmen Vela; Miguel Angel Marín; Luis Emilio Pablo; Alessandra Tessa; María Rosario Barrena; Filippo Maria Santorelli; Claudia Nesti; Pedro Modrego; María Tintoré; José Berciano
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

2.  Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Roxanne Larivière; Rébecca Gaudet; Benoit J Gentil; Martine Girard; Talita Cristiane Conte; Sandra Minotti; Kim Leclerc-Desaulniers; Kalle Gehring; R Anne McKinney; Eric A Shoubridge; Peter S McPherson; Heather D Durham; Bernard Brais
Journal:  Hum Mol Genet       Date:  2014-09-26       Impact factor: 6.150

Review 3.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  Assessment of whole-brain white matter by DTI in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  K K Oguz; G Haliloglu; C Temucin; R Gocmen; A C Has; K Doerschner; A Dolgun; M Alikasifoglu
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

5.  Clinical and molecular studies in two new cases of ARSACS.

Authors:  Ivana Ricca; Federica Morani; Giacomo Maria Bacci; Claudia Nesti; Roberto Caputo; Alessandra Tessa; Filippo Maria Santorelli
Journal:  Neurogenetics       Date:  2019-01-24       Impact factor: 2.660

6.  Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia.

Authors:  Wahiba Hamza; Lamia Ali Pacha; Tarik Hamadouche; Jean Muller; Nathalie Drouot; Farida Ferrat; Samira Makri; Malika Chaouch; Meriem Tazir; Michel Koenig; Traki Benhassine
Journal:  BMC Med Genet       Date:  2015-06-12       Impact factor: 2.103

Review 7.  Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.

Authors:  Marjolaine Tremblay; Laura Girard-Côté; Bernard Brais; Cynthia Gagnon
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

8.  Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?

Authors:  Elena Garcia-Martin; Luis E Pablo; Jose Gazulla; Vicente Polo; Antonio Ferreras; Jose M Larrosa
Journal:  Br J Ophthalmol       Date:  2012-10-17       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.